Brawn Laboratories Limited Enoxaparin Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Enoxaparin Export Records India — #5 Exporter, 72 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Enoxaparin

India Pharmaceutical Trade Intelligence

$209.4M223 Suppliers118 CountriesHS 30049099

ExportsIndia → UNITED STATES49.0%India → SAUDI ARABIA22.0%

ImportsFRANCE → India$2.7B CHINA → India$3.2M

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Brawn Laboratories Limited — Enoxaparin Exporter #5 | $3.6M Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Enoxaparin Exporter Profile

Indian Pharmaceutical Exporter · #5 for Enoxaparin · $3.6M export value · DGFT Verified

Brawn Laboratories Limited is the #5 Indian exporter of Enoxaparin with $3.6M in export value and 72 verified shipments. Brawn Laboratories Limited holds a 1.7% market share in Enoxaparin exports across 7 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Enoxaparin Export Profile: Buyers & Destinations

Brawn Laboratories Limited Enoxaparin export treemap — buyers and destination countries | TransData Nexus

Where Does Brawn Laboratories Limited Export Enoxaparin?

Country	Value	Shipments	Share
PHILIPPINES	$776.8K	29	52.5%
DOMINICAN REPULIC	$205.0K	7	13.9%
SRI LANKA	$200.0K	4	13.5%
DOMINICAN REPUBLIC	$157.8K	4	10.7%

Who Are the Top Buyers of Enoxaparin from Brawn Laboratories Limited?

Buyer	Country	Value	Orders
AMBICA INTERNATIONAL CORPORATION	PHILIPPINES	$637.4K	24
PEOPLE'S BANK	SRI LANKA	$150.0K	3
BANCO POPULAR DOMINICANO	DOMINICAN REPUBLIC	$107.8K	3
SAI PHARMACEUTICALS KENYA LIMITED	KENYA	$59.0K	8
I AND M BANK LTD	KENYA	$53.4K	6
PEOPLES BANK	SRI LANKA	$50.0K	1
GENERICOS DEL CARIBE C ACTIVO	DOMINICAN REPUBLIC	$50.0K	1
GENERICOS DEL CARIBE	DOMINICAN REPULIC	$37.6K	3
GENERICOS DEL CARIBE S.R.L.	DOMINICAN REPULIC	$17.4K	1
ECO ASIA COMPANY LIMITED	MYANMAR	$11.8K	2

Brawn Laboratories Limited supplies Enoxaparin to 14 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by PEOPLE'S BANK (SRI LANKA) and BANCO POPULAR DOMINICANO (DOMINICAN REPUBLIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Enoxaparin Formulations Does Brawn Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
(BNOXIPARIN 40)EACH PREFILLED SYRINGE CONTS:ENOXAPARIN SODIUM USP 40MG(PORCINE DERIVED) WATER FOR INJECTION USP QS.TO 0.NOS	$150.0K	3
EACH PREFILLED SYRINGE CONTAINS ENOXAPARIN SODIUM USP 20MG PORCINE DERIVED WATER FOR INJECTION USP Q S TO 0 2ML	$150.0K	3
ENOXAPARIN SODIUM USP 20MG/0.2ML INJECTI	$107.8K	3
ENOXAPARIN SODIM USP 60MG/0.6ML INJECTION CLEAR COLOURLESS SOLUTION FILLED INIPRE-FILLED TRANSPARENT SYRINGE B.NO.BNI0	$67.2K	2
ENOXAPARIN SODIM USP 40MG/0.4ML INJECTION CLEAR COLOURLESS SOLUTION FILLED INIIPRE-FILLED TRANSPARENT SYRINGE B.NO.BNI	$50.9K	2
EACH PREFILLED SYRINGE CONTS. ENOXAPARINSODIUM USP 40MG (PORCINE DERIVED )WATERFOR INJECTION USP Q.S. TO 0.4ML,(BICANO	$50.5K	2
ENOXAPARIN SODIUM USP 40MG/0.4ML INJECTION CLEAR COLOURELESS SOLUTION FILLED INI PRE-FILLED TRANSPARENT SYRINGE BATCH	$50.3K	2
ENOXAPARIN SODIUM USP 40MG/0.4ML INJECTI	$50.0K	1
EACH PREFILLED SYRINGE CONTAINS: ENOXAPARIN SODIUM USP 40MG PORCINE DERIVED WATER FOR INJECTION USP Q.S. TO 0.4ML B.NO	$50.0K	1
(BNOXIPARIN 40)EACH PREFILLED SYRINGE CONTS. ENOXAPARIN SODIUM USP 40MG PORCINEDERIVED)WATER FOR INJ. USP Q.S. TO 0.4ML	$43.9K	4

Brawn Laboratories Limited exports 49 distinct Enoxaparin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is (BNOXIPARIN 40)EACH PREFILLED SYRINGE CONTS:ENOXAPARIN SODIU with 3 shipments worth $150.0K.

How Does Brawn Laboratories Limited Compare to Nearest Enoxaparin Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	VENUS REMEDIES LIMITED	$5.1M	182	22	$27.8K
6	EMCURE PHARMACEUTICALS LIMITED	$4.1M	187	16	$21.8K
5	BRAWN LABORATORIES LIMITED ★	$3.6M	72	7	$50.0K
8	TROIKAA PHARMACEUTICALS LIMITED	$2.3M	53	13	$43.1K
7	BIOLOGICAL E LIMITED	$900.0K	18	4	$50.0K

Brawn Laboratories Limited ranks #5 among 223 Indian Enoxaparin exporters. Average shipment value of $50.0K compared to the market average of $397.9K. The closest competitors by value are VENUS REMEDIES LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Enoxaparin Exports?

Port	Shipments	% Share
HYDERABAD ICD	555	16.8%
HYDERABAD ICD (INSNF6)	455	13.8%
SAHAR AIR CARGO ACC (INBOM4)	276	8.3%
SAHAR AIR	251	7.6%
DELHI AIR CARGO ACC (INDEL4)	165	5.0%
DELHI AIR	159	4.8%
NHAVA SHEVA SEA (INNSA1)	150	4.5%
HYDERABAD AIR	120	3.6%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Enoxaparin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 72 individual customs records matching Brawn Laboratories Limited exporting Enoxaparin, covering 49 formulations to 8 countries via 14 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 118+ countries, 505+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Enoxaparin

Enoxaparin

Brawn Laboratories Limited — Enoxaparin Exporter Profile

Brawn Laboratories Limited — Enoxaparin Export Profile: Buyers & Destinations

Where Does Brawn Laboratories Limited Export Enoxaparin?

Who Are the Top Buyers of Enoxaparin from Brawn Laboratories Limited?

What Is India's Total Enoxaparin Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Enoxaparin Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Enoxaparin Exporters?

What Enoxaparin Formulations Does Brawn Laboratories Limited Export?

How Does Brawn Laboratories Limited Compare to Nearest Enoxaparin Exporters?

Which Indian Ports Ship Enoxaparin Exports?

What Other Cardiovascular Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Enoxaparin Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Enoxaparin Export Data from Brawn Laboratories Limited

Enoxaparin Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source